PP_1170x120_10-25-21

Alvogen’s Fluoxetine Tablets

Lupin gets FDA nod for depression drug

Lupin gets FDA nod for depression drug

BALTIMORE, Md. — Lupin announced on Tuesday that it has received approval from the United States Food and Drug Administration (FDA) to market a generic version of Alvogen’s Fluoxetine Tablets, 60mg. Fluoxetine is indicated in the treatment of major depressive disorders. Fluoxetine Tablets, 60mg, had annual sales of approximately $42.5m in the U.S.